Magnetar Financial LLC Purchases New Stake in Privia Health Group, Inc. $PRVA

Magnetar Financial LLC acquired a new position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 11,493 shares of the company’s stock, valued at approximately $264,000.

Several other institutional investors have also recently added to or reduced their stakes in PRVA. CWM LLC lifted its position in shares of Privia Health Group by 50.3% in the 1st quarter. CWM LLC now owns 1,804 shares of the company’s stock worth $40,000 after buying an additional 604 shares during the last quarter. Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in Privia Health Group during the first quarter worth about $625,000. Avantax Advisory Services Inc. lifted its holdings in Privia Health Group by 19.7% in the first quarter. Avantax Advisory Services Inc. now owns 15,039 shares of the company’s stock worth $338,000 after acquiring an additional 2,474 shares during the last quarter. Cetera Investment Advisers boosted its stake in Privia Health Group by 3.9% in the first quarter. Cetera Investment Advisers now owns 61,936 shares of the company’s stock valued at $1,390,000 after acquiring an additional 2,338 shares during the period. Finally, Federated Hermes Inc. boosted its stake in Privia Health Group by 19.3% in the first quarter. Federated Hermes Inc. now owns 29,728 shares of the company’s stock valued at $667,000 after acquiring an additional 4,804 shares during the period. Institutional investors own 94.48% of the company’s stock.

Privia Health Group Stock Performance

NASDAQ:PRVA opened at $24.46 on Thursday. The stock has a market cap of $3.01 billion, a price-to-earnings ratio of 188.17, a PEG ratio of 4.09 and a beta of 0.83. Privia Health Group, Inc. has a 1 year low of $18.77 and a 1 year high of $26.51. The business has a fifty day moving average of $24.33 and a 200-day moving average of $22.78.

Privia Health Group (NASDAQ:PRVA) last issued its quarterly earnings data on Tuesday, June 7th. The company reported $0.10 earnings per share for the quarter. The business had revenue of $213.61 million for the quarter. Privia Health Group had a net margin of 0.89% and a return on equity of 2.52%. On average, equities research analysts predict that Privia Health Group, Inc. will post 0.14 EPS for the current year.

Analyst Upgrades and Downgrades

PRVA has been the topic of a number of research reports. Piper Sandler cut their price target on Privia Health Group from $36.00 to $35.00 and set an “overweight” rating on the stock in a report on Monday, August 11th. Zacks Research raised Privia Health Group from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 19th. JPMorgan Chase & Co. raised their target price on Privia Health Group from $32.00 to $33.00 and gave the company an “overweight” rating in a research note on Thursday, November 13th. JMP Securities upped their price target on shares of Privia Health Group from $29.00 to $30.00 and gave the stock a “market outperform” rating in a research report on Friday, August 29th. Finally, Truist Financial reaffirmed a “buy” rating and issued a $31.00 price objective (up previously from $30.00) on shares of Privia Health Group in a report on Monday, November 10th. Thirteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, Privia Health Group has a consensus rating of “Moderate Buy” and a consensus target price of $30.00.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.